Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy

The J‐CAPRA score is an assessment tool which stratifies risk and predicts outcome of primary androgen deprivation therapy (ADT) using prostate‐specific antigen, Gleason score, and clinical TNM staging. Here, we aimed to assess the generalisability of this tool in multi‐ethnic Asians. Performance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jasmine, Hinotsu, Shiro, Onozawa, Mizuki, Malek, Rohan, Sundram, Murali, Teh, Guan C., Ong, Teng‐Aik, Thevarajah, Shankaran, Zainal, Rohana, Khoo, Say C., Omar, Shamsuddin, Nasuha, Noor A., Akaza, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774710/
https://www.ncbi.nlm.nih.gov/pubmed/33098372
http://dx.doi.org/10.1002/cam4.3548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774710/
https://www.ncbi.nlm.nih.gov/pubmed/33098372
http://dx.doi.org/10.1002/cam4.3548

Ejemplares similares